Navigation Links
Rusty worms in the brain
Date:3/5/2008

This release is available in German.

Iron is vital to human life; for example, it is a component of hemoglobin, the substance that makes our blood red and supplies our cells with oxygen. However, iron can also cause heavy damage; it is thought that iron deposits in the brain contribute to certain forms of neurodegenerative diseases such as Parkinsons, Huntington s, and Alzhiemers. A malfunction of the blood transporter transferrin may be to blame. A team led by Peter J. Sadler at the University of Warwick (Coventry, UK) and Sandeep Verma of the Indian Institute of Technology (Kanpur, India) has now been able to show that transferrin can clump together to form wormlike fibrils. As reported in the journal Angewandte Chemie, this process releases rustlike iron particles.

Within the body, iron is present in the form of iron ions with a threefold positive charge (Fe3+) and must always be well wrapped to prevent it from reacting with proteins and causing damage. In blood plasma, iron is carried in the pockets of the iron transport protein transferrin. It only gets unwrapped once it is inside special cellular organelles.

But things can go wrong in this system, as Sadler and his colleagues have now proven. The researchers deposited iron-loaded human transferrin onto various surfaces under conditions that emulate those in living organisms. By using microscopy and electron microscopy, the researchers showed that the proteins aggregate into long wormlike fibrils. These worms have a regular striped pattern; the narrow dark stripes contain something similar to rust. Within the fibrils, the iron ions are no longer properly enclosed; explains Sadler, instead, they aggregate into periodically arranged nanocrystals whose structure seems to be very similar to the iron oxide mineral lepidocrocite.

The researchers suspect that in certain forms of neurodegenerative disease, iron deposits may form in a similar fashion in the brain. Such iron crystals are highly reactive and could lead to the formation of toxic free radicals, which attack and destroy nerve cells. If this assumption can be verified in vivo, agents that hinder the aggregation of transferrin may be the foundation for a new family of drugs.


'/>"/>

Contact: Peter J. Sadler
p.j.sadler@warwick.ac.uk
44-247-652-3653
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. After more than 100 years apart, webworms devastate New Zealand parsnips
2. Snoozing worms help Penn researchers explain the evolution of sleep
3. Worms take the sniff test to reveal sex differences in brain
4. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
5. Scientists alter sexual orientation in worms
6. The myth of runners high revisited with brain imaging
7. Brains R Us: Neuroscience and education town hall
8. Advertisers, neuroscientists trace source of emotions in brain
9. Sex differences in the brains serotonin system
10. Book is the first high-resolution digital mouse brain atlas designed for Web applications
11. New MIT tool probes brain circuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/6/2017)... Calif. , Jan. 5, 2017  Delta ID ... its iris scanning technology for automotive at CES® 2017. ... GNTX ) to demonstrate the use of iris ... identify and authenticate the driver in a car, and ... during the driving experience. Delta ID and ...
(Date:1/4/2017)... Jan. 4, 2017  CES 2017 – Valencell ... technology, today announced the launch of two new ... the highly-accurate biometric sensor modules that incorporate the ... experience and expertise. The two new designs include ... for hearables, and Benchmark BW2.0, a 2-LED version ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... MD (PRWEB) , ... January 18, 2017 , ... ... the National Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, ... “scoreable” element of grant applications subject to the existing policy. AMIA recommended that ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... drug and device development, and Prism Clinical Research , a leader in ... Verified Clinical Trials (VCT) has been selected by both companies as ...
(Date:1/19/2017)... 2017 Acupath Laboratories, Inc., a leading provider ... an Executive Committee that will guide the company,s vision ... John Cucci , a 15-year veteran of the anatomic ... Development to Chief Sales Officer .  Prior to ... senior sales leadership roles at several leading lab industry ...
Breaking Biology Technology: